Waldemar Priebe
Geen lopende functies
Profiel
Waldemar Priebe is the founder of Reata Pharmaceuticals, Inc. (founded in 2002), Moleculin Biotech, Inc. (founded in 2015), and CNS Pharmaceuticals, Inc. (founded in 2017).
Eerdere bekende functies van Waldemar Priebe
| Bedrijven | Functie | Einde |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Founder | - |
| CNS PHARMACEUTICALS, INC. | Founder | - |
| REATA PHARMACEUTICALS, INC. | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
